Literature DB >> 16487235

ASCOT--old or new drugs for blood pressure?

James Ritter, John Warren.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16487235      PMCID： PMC1885030          DOI： 10.1111/j.1365-2125.2006.02564.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  The verdict from ALLHAT--thiazide diuretics are the preferred initial therapy for hypertension.

Authors:  Lawrence J Appel
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

2.  Evidence that new antihypertensives are superior to older drugs.

Authors:  Jan A Staessen; Willem H Birkenhäger
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

Review 3.  Clinical Implications of Recent Findings from the Antihypertensive and Lipid-Lowering Treatment To Prevent Heart Attack Trial (ALLHAT) and Other Studies of Hypertension.

Authors:  C D Furberg; B M Psaty; M Pahor; M H Alderman
Journal:  Ann Intern Med       Date:  2001-12-18       Impact factor: 25.391

4.  Atenolol in hypertension: is it a wise choice?

Authors:  Bo Carlberg; Ola Samuelsson; Lars Hjalmar Lindholm
Journal:  Lancet       Date:  2004 Nov 6-12       Impact factor: 79.321

5.  MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-13

Review 6.  beta-Blockers in hypertension-the emperor has no clothes: an open letter to present and prospective drafters of new guidelines for the treatment of hypertension.

Authors:  Franz H Messerli; D Gareth Beevers; Stanley S Franklin; Thomas G Pickering
Journal:  Am J Hypertens       Date:  2003-10       Impact factor: 2.689
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.